Recombinant ACPP anticorps (AA 1-100)
Aperçu rapide pour Recombinant ACPP anticorps (AA 1-100) (ABIN7867786)
Antigène
Voir toutes ACPP AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 1-100
-
Fonction
- Prostatic acid phosphatase Antibody / PAP / PSAP / ACP3
-
Purification
- Protein A/G affinity
-
Immunogène
- A recombinant partial protein sequence (within amino acids 1-100) from the human protein was used as the immunogen for the Prostatic acid phosphatase antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Indications d'application
- Optimal dilution of the Prostatic acid phosphatase antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Prostatic acid phosphatase antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ACPP (Acid Phosphatase, Prostate (ACPP))
-
Autre désignation
- Prostatic acid phosphatase
-
Sujet
- Prostatic Acid Phosphatase (PSAP or PAP) is a member of the histidine acid phosphatase family. It is a non-specific phosphatase that is capable of dephosphorylating tyrosine residues as well as phospholipids under mildly acidic conditions. Prostatic specific acid phosphatase (PSAP) is involved in prostate epithelial differentiation. It is highly expressed in prostate, primary and metastatic carcinoma of the prostate. This marker may be helpful in pinpointing the site of origin in cases of metastatic carcinoma of the prostate, and is considered a more sensitive marker than PSA.
-
UniProt
- P15309
-
Pathways
- Synaptic Membrane, Ribonucleoside Biosynthetic Process
Antigène
-